What is a stock summary page? Click here for an overview.
Business Description

AgeX Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US00848H1086
Description
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. Its PureStem-derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.
Financial Strength
2/10
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
3/10
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -48.29 | |||||
12-1 Month Momentum % | -48.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -5522.9 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History |
---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AgeX Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.131 | ||
EPS (TTM) (€) | -12.779 | ||
Beta | - | ||
3-Year Sharpe Ratio | -0.13 | ||
3-Year Sortino Ratio | -0.21 | ||
Volatility % | 53.77 | ||
14-Day RSI | - | ||
14-Day ATR (€) | 0.763692 | ||
20-Day SMA (€) | - | ||
12-1 Month Momentum % | -48.29 | ||
52-Week Range (€) | 10.058619 - 23.563899 | ||
Shares Outstanding (Mil) | 2.5 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AgeX Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AgeX Therapeutics Inc Stock Events
Event | Date | Price (€) | ||
---|---|---|---|---|
No Event Data |
AgeX Therapeutics Inc Frequently Asked Questions
What is AgeX Therapeutics Inc(FRA:0X40)'s stock price today?
The current price of FRA:0X40 is €17.44. The 52 week high of FRA:0X40 is €23.56 and 52 week low is €10.06.
When is next earnings date of AgeX Therapeutics Inc(FRA:0X40)?
The next earnings date of AgeX Therapeutics Inc(FRA:0X40) is 2025-05-31 Est..
Does AgeX Therapeutics Inc(FRA:0X40) pay dividends? If so, how much?
AgeX Therapeutics Inc(FRA:0X40) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |